Natoli Engineering Company partnered with the Brooklyn campus of Long Island University to open the Natoli Institute for Industrial Pharmacy Research and Development.Natoli Engineering Company announced the opening of the Natoli Institute for Industrial Pharmacy Research and Development. The institute was opened in partnership with the Arnold and Marie Schwartz College of Pharmacy and Health Sciences on the Brooklyn campus of Long Island University and features suites for dispensing, formulation, compression, and coating.
Natoli Engineering Company announced the opening of the Natoli Institute for Industrial Pharmacy Research and Development. The institute was opened in partnership with the Arnold and Marie Schwartz College of Pharmacy and Health Sciences on the Brooklyn campus of Long Island University and features suites for dispensing, formulation, compression, and coating.
According to Natoli, the institute was established to further pharmaceutical compression science and support research into the industry’s most complex challenges. The laboratory will provide research opportunities to undergraduate and graduate students to enable them to find innovative solutions to formulation problems through research and implementation. The institute will provide an environment for students to learn industrial pharmacy unit operations for solid oral-dosage forms, with a focus on understanding problems associated with the compression of tablets, the development of formulations for new and existing molecules, and the measurements required to ensure proper delivery of formulations to a tablet press and the control of the press.
The Natoli Institute will also provide an opportunity for Natoli customers to have their tableting problems investigated, such as sticking, picking, tablet disintegration/dissolution, bioavailability, and formulation and feasibility experiments.
Source: Natoli Engineering Company
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.